While its not yet approved in Ireland, Retatrutide is currently in late-stage clinical trials, with availability expected from 2026 onwards
Retrieved from Aldawsari, M., Almadani, F
Rarely reported symptoms associated with excessive B12 intake may include: Skin reactions : Acne-like eruptions or rosacea-type dermatitis have been occasionally reported, particularly with high-dose intramuscular injections Gastrointestinal disturbance : Mild nausea, diarrhoea, or abdominal discomfort, though these are uncommon Headache : Infrequent reports of headaches following parenteral B12 administration Hypersensitivity reactions : In very rare cases, allergic reactions to injectable B12 preparations have been documented It is crucial to note that there is no established link between standard B12 supplementation and serious adverse effects
But we cant find a receptor, cant name a target, and cant find a gene for it in your genome is just giving up on science entirely
Cons Some of the products can be pricey